Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 16, Issue 37
  5. Article
Volume 16, Issue 37
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

This review describes the clinical application of β-adrenergic blocking drugs over time in patients with congestive heart failure. The different pharmacological properties of these drugs in relation to clinical outcomes raise questions as to their optimal desirable profile based on studies showing the undesirable effects of excessive β2-AR activation. The rationale for the use of selective β2-AR antagonists in heart failure is discussed.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161210794519200
2010-12-01
2025-04-10

  • From This Site

    /content/journals/cpd/10.2174/138161210794519200
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161210794519200
Loading

  • Article Type:     Research Article
Keyword(s): heart failure; MAP/ERK activation; Selective adrenoceptor blockade

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test